Correlation Between Dominari Holdings and Sino Biopharmaceutica
Can any of the company-specific risk be diversified away by investing in both Dominari Holdings and Sino Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dominari Holdings and Sino Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dominari Holdings and Sino Biopharmaceutical Limited, you can compare the effects of market volatilities on Dominari Holdings and Sino Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dominari Holdings with a short position of Sino Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dominari Holdings and Sino Biopharmaceutica.
Diversification Opportunities for Dominari Holdings and Sino Biopharmaceutica
0.09 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Dominari and Sino is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Dominari Holdings and Sino Biopharmaceutical Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sino Biopharmaceutical and Dominari Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dominari Holdings are associated (or correlated) with Sino Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sino Biopharmaceutical has no effect on the direction of Dominari Holdings i.e., Dominari Holdings and Sino Biopharmaceutica go up and down completely randomly.
Pair Corralation between Dominari Holdings and Sino Biopharmaceutica
Given the investment horizon of 90 days Dominari Holdings is expected to under-perform the Sino Biopharmaceutica. But the stock apears to be less risky and, when comparing its historical volatility, Dominari Holdings is 1.46 times less risky than Sino Biopharmaceutica. The stock trades about -0.02 of its potential returns per unit of risk. The Sino Biopharmaceutical Limited is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 52.00 in Sino Biopharmaceutical Limited on September 2, 2024 and sell it today you would lose (10.00) from holding Sino Biopharmaceutical Limited or give up 19.23% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 62.1% |
| Values | Daily Returns |
Dominari Holdings vs. Sino Biopharmaceutical Limited
Performance |
| Timeline |
| Dominari Holdings |
| Sino Biopharmaceutical |
Dominari Holdings and Sino Biopharmaceutica Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dominari Holdings and Sino Biopharmaceutica
The main advantage of trading using opposite Dominari Holdings and Sino Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dominari Holdings position performs unexpectedly, Sino Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sino Biopharmaceutica will offset losses from the drop in Sino Biopharmaceutica's long position.| Dominari Holdings vs. CytomX Therapeutics | Dominari Holdings vs. Instil Bio | Dominari Holdings vs. Spero Therapeutics | Dominari Holdings vs. Assembly Biosciences |
| Sino Biopharmaceutica vs. Rigel Pharmaceuticals | Sino Biopharmaceutica vs. Geron | Sino Biopharmaceutica vs. Verastem | Sino Biopharmaceutica vs. Immutep Ltd ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |